1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Oceania Countries, September 2014 (p5)

Pharmaceutical Analysis & Statistics in Oceania Countries, September 2014 (p5)

121-150 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Pharmacies in Australia - Industry Market Research Report

Pharmacies in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • September 2014
  • by Ibisworld

Effective treatment: Industry will return to growth as business models evolve Pharmacies in Australia The industry includes all community pharmacies that sell prescription drugs and patent medicines ...

  • Industries : Pharmacies and Drug Stores
  • Countries : Australia
Online Vitamin and Supplement Sales in Australia - Industry Market Research Report

Online Vitamin and Supplement Sales in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • September 2014
  • by Ibisworld

Supplementary services: Firms offer online consultation to compete with physical stores Online Vitamin and Supplement Sales in Australia This industry includes specialist online retailers of vitamins, ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement
  • Countries : Australia
Pharmaceuticals Packing and Labelling Services in Australia - Industry Market Research Report

Pharmaceuticals Packing and Labelling Services in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • September 2014
  • by Ibisworld

Packing a punch: Revenue will keep rising as firms and manufacturers stay co-dependent Pharmaceuticals Packing and Labelling Services in Australia Industry operators provide packaging and labelling services ...

  • Industries : Pharmaceutical
  • Countries : Australia
PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • August 2014
  • by Global Data

PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented ...

  • Industries : Pathology, Drug and Medication
  • Countries : Australia
Australia Hernia Repair Procedures Outlook to 2020

Australia Hernia Repair Procedures Outlook to 2020

  • $ 1 000
  • Industry report
  • July 2014
  • by Global Data

Australia Hernia Repair Procedures Outlook to 2020 Summary GlobalData’s new report, "Australia Hernia Repair Procedures Outlook to 2020", provides key market data on the Australia Hernia Repair Procedures. ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Healthcare, Pharmaceutical
  • Countries : Australia, Oceania
Australia General Surgery Outlook to 2020

Australia General Surgery Outlook to 2020

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Australia General Surgery Outlook to 2020 Summary GlobalData’s new report, "Australia General Surgery Outlook to 2020", provides key market data on the Australia General Surgery Procedures. The report ...

  • Industries : Medical Equipment and Supply, Medical Devices, General Medicine and Specialty Medicine, Healthcare, Pathology, Pharmaceutical
  • Countries : Australia, Oceania
Pharmaceuticals Wholesaling in Australia - Industry Market Research Report

Pharmaceuticals Wholesaling in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • July 2014
  • by Ibisworld

No spoonful of sugar: Tight industry control and wholesale bypass will restrain profitability Pharmaceuticals Wholesaling in Australia The industry comprises companies that wholesale human-use pharmaceutical ...

  • Industries : Pharmaceutical
  • Countries : Australia
Pharmaceutical Product Manufacturing in Australia - Industry Market Research Report

Pharmaceutical Product Manufacturing in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • July 2014
  • by Ibisworld

Bitter pill: Industry players must adapt as more drugs lose patent protection Pharmaceutical Product Manufacturing in Australia The industry comprises companies that manufacture various medicinal and ...

  • Industries : Pharmaceutical
  • Countries : Australia
Vitamin and Supplement Stores in Australia - Industry Market Research Report

Vitamin and Supplement Stores in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • July 2014
  • by Ibisworld

Healthy growth: Health consciousness and sports participation help industry performance Vitamin and Supplement Stores in Australia This industry consists of physical stores that mainly sell vitamins ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement
  • Countries : Australia
Pathology Services in Australia - Industry Market Research Report

Pathology Services in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • July 2014
  • by Ibisworld

Subdued results: Decline in average fee per service partly offsets gains from greater demand Pathology Services in Australia Companies in this industry operate pathology laboratories and collection centres. ...

  • Industries : Pathology
  • Countries : Australia
Pharmacybrands Ltd in Consumer Health (New Zealand)

Pharmacybrands Ltd in Consumer Health (New Zealand)

  • $ 143
  • Company report
  • July 2014
  • by Euromonitor International

Pharmacybrands Ltd is expected to continue expanding its retail network of chemists/pharmacies across New Zealand through its five banners; Amcal, Care Chemist, Radius Pharmacy, Life Pharmacy and Unichem. ...

  • Countries : New Zealand
Pain Medication OTC Manufacturing in Australia - Industry Market Research Report

Pain Medication OTC Manufacturing in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • June 2014
  • by Ibisworld

Growth pains: Tighter regulatory controls constrain industry revenue growth Pain Medication OTC Manufacturing in Australia Companies in this industry research and develop over-the-counter pain relief ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Australia
QRxPharma Limited - Product Pipeline Review - 2014

QRxPharma Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

QRxPharma Limited - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘QRxPharma Limited - Product Pipeline Review - 2014’, provides an overview of the QRxPharma Limited’s pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : World, China, Australia
Crisis and Care Accommodation in Australia - Industry Market Research Report

Crisis and Care Accommodation in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • June 2014
  • by Ibisworld

Caring in tough times: Economic pressures are set to increase industry demand Crisis and Care Accommodation in Australia This industry provides residential care accommodation (except aged care) combined ...

  • Industries : Pathology
  • Countries : Australia
Sigma Pharmaceuticals Ltd in Retailing (Australia)

Sigma Pharmaceuticals Ltd in Retailing (Australia)

  • $ 143
  • Company report
  • June 2014
  • by Euromonitor International

After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals ...

  • Industries : Pharmaceutical
  • Countries : Australia
Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Drug and Medication
  • Countries : World, Australia, Japan
Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication, Pathology
  • Countries : World, Australia, Japan
Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market ...

  • Industries : Drug and Medication
  • Countries : Australia
ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication, Pathology
  • Countries : World, Australia
Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.